Gemcitabine With/Out Erlotinib in Unresectable Locally Advanced/Metastatic Pancreatic Cancer
Completed · Phase 3 · Has a placebo group
Conditions studied: Pancreatic Cancer
In brief
RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. Biological therapies such as erlotinib use different ways to stimulate the immune system and stop cancer cells from growing. Combining chemotherapy and biological therapy may kill more tumor cells. It is not yet known if gemcitabine is more effective with or without erlotinib in treating pancreatic cancer. PURPOSE: Randomized phase III trial to determine the effectiveness of gemcitabine with and without erlotinib in treating patients who have unresectable locally advanced or metastatic pancreatic cancer.
Key facts
- Study ID
- NCT00026338
- Run by
- NCIC Clinical Trials Group
- People needed
- 569
- Starts
- 2001-10-29
- Expected to finish
- 2009-02-10
- Last updated by the study team
- 2020-04-02
Who can join
Age: 18 and older, up to 120. Sex: any. Healthy volunteers: not accepted.
Where it is running
- Highlands Oncology Group — Springdale, Arkansas, United States
- Alta Bates Comprehensive Cancer Center — Berkeley, California, United States
- Sutter Health West Cancer Research Group — Greenbrae, California, United States
- Loma Linda University Cancer Institute — Loma Linda, California, United States
- USC/Norris Comprehensive Cancer Center and Hospital — Los Angeles, California, United States
- Kenmar Research Institute — Los Angeles, California, United States
- Century City Hospital — Los Angeles, California, United States
- David Geffen School of Medicine — Los Angeles, California, United States
- Kaiser Permanente Medical Center/Kaiser Foundation Hospital - San Diego — San Diego, California, United States
- Davis, Posteraro, & Wasser, MDs, LLP — Manchester, Connecticut, United States
- New Britain General Hospital — New Britain, Connecticut, United States
- Eastern Connecticut Hematology and Oncology Associates — Norwich, Connecticut, United States
- Hematology Oncology, P.C. — Stamford, Connecticut, United States
- Florida Cancer Specialists — Fort Myers, Florida, United States
- Oncology-Hematology Group of South Florida — Miami, Florida, United States
- Ocala Oncology Center — Ocala, Florida, United States
- Oncology & Hematology Associates of West Broward — Tamarac, Florida, United States
- Moffitt Clinic at Tampa General Hospital — Tampa, Florida, United States
- Central Georgia Hematology Oncology, P.C. — Macon, Georgia, United States
- Mountain States Tumor Institute — Boise, Idaho, United States
- Northwest Medical Specialists, P.C. — Arlington Heights, Illinois, United States
- Veterans Affairs Medical Center - Hines (Hines Junior VA Hospital) — Hines, Illinois, United States
- Oncology/Hematology Associates of Central Illinois, P.C. — Peoria, Illinois, United States
- Midwest Cancer Research Group, Inc. — Skokie, Illinois, United States
- Arizona Clinical Research Center — Tucson, Arizona, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.